Jessica Federer built her career inside the rooms where science, money, and power collide. As the first female Chief Digital Officer at Bayer, she helped steer a 120,000 person global company through the rise of digital medicine while confronting a harder truth: women were excluded from U.S. clinical trials until 1993. In this conversation, she explains how decades of “first in man” research shaped drug development, why women experience side effects at nearly 2x the rate of men, and how guidance on sex based differences did not arrive from the FDA until December 2025. She shares what...
Für diese Folge gibt es noch kein Transkript
Sie können sie trotzdem im Player anhören. Bei Folgen mit Transkript tippen Sie auf ein Wort, um seine Bedeutung zu sehen.
![[BEST OF OOP] Jessica J. Federer](/_next/image?url=https%3A%2F%2Fcontent.production.cdn.art19.com%2Fimages%2F4b%2Ff8%2F18%2F85%2F4bf81885-f746-4452-a17b-afdb671b3193%2F909a69502f3c5b10d12f597de7823cc2c70e90ed44261716331d63875746ab363947752d28ddf868ed81c98c2cfdd76823e0a2a77c68722f43333fbddc09a6c5.jpeg&w=384&q=75)